Continued utilization and costs of proton pump inhibitors after Helicobacter pylori eradication in chronic users of gastrointestinal drugs

Aliment Pharmacol Ther. 2002 May;16(5):1033-4. doi: 10.1046/j.1365-2036.2002.01246.x.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Amoxicillin / economics
  • Amoxicillin / therapeutic use
  • Clarithromycin / economics
  • Clarithromycin / therapeutic use
  • Cost-Benefit Analysis
  • Databases, Factual
  • Gastrointestinal Agents / economics
  • Gastrointestinal Agents / therapeutic use*
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori*
  • Humans
  • Netherlands
  • Proton Pump Inhibitors*

Substances

  • Gastrointestinal Agents
  • Proton Pump Inhibitors
  • Amoxicillin
  • Clarithromycin